Logo image of TOUR

TUNIU CORP-SPON ADR (TOUR) Stock Fundamental Analysis

NASDAQ:TOUR - Nasdaq - US89977P1066 - ADR - Currency: USD

0.875  +0.01 (+0.77%)

After market: 0.8775 +0 (+0.29%)

Fundamental Rating

5

Taking everything into account, TOUR scores 5 out of 10 in our fundamental rating. TOUR was compared to 131 industry peers in the Hotels, Restaurants & Leisure industry. Both the profitability and the financial health of TOUR get a neutral evaluation. Nothing too spectacular is happening here. TOUR has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

TOUR had positive earnings in the past year.
TOUR had a positive operating cash flow in the past year.
TOUR had negative earnings in 4 of the past 5 years.
In multiple years TOUR reported negative operating cash flow during the last 5 years.
TOUR Yearly Net Income VS EBIT VS OCF VS FCFTOUR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500M -1B -1.5B -2B

1.2 Ratios

Looking at the Return On Assets, with a value of 4.03%, TOUR is in the better half of the industry, outperforming 62.60% of the companies in the same industry.
The Return On Equity of TOUR (7.12%) is better than 64.12% of its industry peers.
TOUR's Return On Invested Capital of 6.07% is in line compared to the rest of the industry. TOUR outperforms 56.49% of its industry peers.
Industry RankSector Rank
ROA 4.03%
ROE 7.12%
ROIC 6.07%
ROA(3y)-3.76%
ROA(5y)-11.5%
ROE(3y)-6.63%
ROE(5y)-24.79%
ROIC(3y)N/A
ROIC(5y)N/A
TOUR Yearly ROA, ROE, ROICTOUR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60 -80

1.3 Margins

The Profit Margin of TOUR (14.98%) is better than 88.55% of its industry peers.
The Operating Margin of TOUR (15.18%) is better than 67.18% of its industry peers.
With an excellent Gross Margin value of 69.65%, TOUR belongs to the best of the industry, outperforming 84.73% of the companies in the same industry.
TOUR's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 15.18%
PM (TTM) 14.98%
GM 69.65%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y19.93%
GM growth 5Y8.01%
TOUR Yearly Profit, Operating, Gross MarginsTOUR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200

6

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), TOUR is destroying value.
TOUR has less shares outstanding than it did 1 year ago.
The number of shares outstanding for TOUR has been reduced compared to 5 years ago.
TOUR has a better debt/assets ratio than last year.
TOUR Yearly Shares OutstandingTOUR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
TOUR Yearly Total Debt VS Total AssetsTOUR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.2 Solvency

Based on the Altman-Z score of -4.77, we must say that TOUR is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of -4.77, TOUR is not doing good in the industry: 93.89% of the companies in the same industry are doing better.
There is no outstanding debt for TOUR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z -4.77
ROIC/WACC0.64
WACC9.47%
TOUR Yearly LT Debt VS Equity VS FCFTOUR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B -2B 4B

2.3 Liquidity

A Current Ratio of 1.35 indicates that TOUR should not have too much problems paying its short term obligations.
With a decent Current ratio value of 1.35, TOUR is doing good in the industry, outperforming 68.70% of the companies in the same industry.
TOUR has a Quick Ratio of 1.35. This is a normal value and indicates that TOUR is financially healthy and should not expect problems in meeting its short term obligations.
TOUR's Quick ratio of 1.35 is fine compared to the rest of the industry. TOUR outperforms 71.76% of its industry peers.
Industry RankSector Rank
Current Ratio 1.35
Quick Ratio 1.35
TOUR Yearly Current Assets VS Current LiabilitesTOUR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 177.78% over the past year.
Looking at the last year, TOUR shows a quite strong growth in Revenue. The Revenue has grown by 16.45% in the last year.
TOUR shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -25.77% yearly.
EPS 1Y (TTM)177.78%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%80.56%
Revenue 1Y (TTM)16.45%
Revenue growth 3Y6.46%
Revenue growth 5Y-25.77%
Sales Q2Q%3%

3.2 Future

Based on estimates for the next years, TOUR will show a very negative growth in Earnings Per Share. The EPS will decrease by -21.60% on average per year.
The Revenue is expected to grow by 13.31% on average over the next years. This is quite good.
EPS Next Y-90.36%
EPS Next 2Y-37.91%
EPS Next 3Y-21.6%
EPS Next 5YN/A
Revenue Next Year13.23%
Revenue Next 2Y13.23%
Revenue Next 3Y13.31%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
TOUR Yearly Revenue VS EstimatesTOUR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2B 4B 6B 8B 10B
TOUR Yearly EPS VS EstimatesTOUR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2023 2024 2025 2026 2027 0 -5 -10 -15

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 9.72, which indicates a very decent valuation of TOUR.
TOUR's Price/Earnings ratio is rather cheap when compared to the industry. TOUR is cheaper than 96.18% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 27.35. TOUR is valued rather cheaply when compared to this.
Based on the Price/Forward Earnings ratio of 76.75, the valuation of TOUR can be described as expensive.
Compared to the rest of the industry, the Price/Forward Earnings ratio of TOUR indicates a slightly more expensive valuation: TOUR is more expensive than 65.65% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of TOUR to the average of the S&P500 Index (37.54), we can say TOUR is valued expensively.
Industry RankSector Rank
PE 9.72
Fwd PE 76.75
TOUR Price Earnings VS Forward Price EarningsTOUR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, TOUR is valued a bit cheaper than the industry average as 78.63% of the companies are valued more expensively.
96.95% of the companies in the same industry are more expensive than TOUR, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 8.78
EV/EBITDA 8.75
TOUR Per share dataTOUR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.2 0.4 0.6 0.8 1

4.3 Compensation for Growth

A cheap valuation may be justified as TOUR's earnings are expected to decrease with -21.60% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-37.91%
EPS Next 3Y-21.6%

3

5. Dividend

5.1 Amount

TOUR has a Yearly Dividend Yield of 3.33%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 3.63, TOUR pays a better dividend. On top of this TOUR pays more dividend than 86.26% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.36, TOUR pays a bit more dividend than the S&P500 average.
Industry RankSector Rank
Dividend Yield 3.33%

5.2 History

TOUR is new to the dividend game and has less than 3 years of track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
TOUR Yearly Dividends per shareTOUR Yearly Dividends per shareYearly Dividends per share 2025 0 0 0 0 0

5.3 Sustainability

DPN/A
EPS Next 2Y-37.91%
EPS Next 3Y-21.6%
TOUR Yearly Income VS Free CF VS DividendTOUR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500M -1B -1.5B -2B

TUNIU CORP-SPON ADR

NASDAQ:TOUR (7/24/2025, 8:07:38 PM)

After market: 0.8775 +0 (+0.29%)

0.875

+0.01 (+0.77%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)06-02 2025-06-02
Earnings (Next)08-04 2025-08-04
Inst Owners9.95%
Inst Owner Change0%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap103.00M
Analysts85.71
Price Target1.73 (97.71%)
Short Float %0.41%
Short Ratio0.83
Dividend
Industry RankSector Rank
Dividend Yield 3.33%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-Date03-27 2025-03-27 (0.036)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 9.72
Fwd PE 76.75
P/S 1.43
P/FCF 8.78
P/OCF 7.68
P/B 0.68
P/tB 0.76
EV/EBITDA 8.75
EPS(TTM)0.09
EY10.29%
EPS(NY)0.01
Fwd EY1.3%
FCF(TTM)0.1
FCFY11.39%
OCF(TTM)0.11
OCFY13.02%
SpS0.61
BVpS1.28
TBVpS1.15
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 4.03%
ROE 7.12%
ROCE 7.68%
ROIC 6.07%
ROICexc 6.07%
ROICexgc 6.82%
OM 15.18%
PM (TTM) 14.98%
GM 69.65%
FCFM 16.34%
ROA(3y)-3.76%
ROA(5y)-11.5%
ROE(3y)-6.63%
ROE(5y)-24.79%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y19.93%
GM growth 5Y8.01%
F-Score8
Asset Turnover0.27
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 192.93%
Cap/Sales 2.33%
Interest Coverage 26.17
Cash Conversion 113.99%
Profit Quality 109.09%
Current Ratio 1.35
Quick Ratio 1.35
Altman-Z -4.77
F-Score8
WACC9.47%
ROIC/WACC0.64
Cap/Depr(3y)99.5%
Cap/Depr(5y)69.38%
Cap/Sales(3y)2.7%
Cap/Sales(5y)3.57%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)177.78%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%80.56%
EPS Next Y-90.36%
EPS Next 2Y-37.91%
EPS Next 3Y-21.6%
EPS Next 5YN/A
Revenue 1Y (TTM)16.45%
Revenue growth 3Y6.46%
Revenue growth 5Y-25.77%
Sales Q2Q%3%
Revenue Next Year13.23%
Revenue Next 2Y13.23%
Revenue Next 3Y13.31%
Revenue Next 5YN/A
EBIT growth 1Y477.78%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year525.16%
EBIT Next 3Y111.83%
EBIT Next 5YN/A
FCF growth 1Y-62.37%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-58.8%
OCF growth 3YN/A
OCF growth 5YN/A